These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15479291)

  • 1. Long-term survival following radical prostatectomy in Japanese men with clinically localized prostate cancer: a single institutional study.
    Hachiya T; Okada Y; Kawata N; Hirano D; Yoshida T; Okada K; Takimoto Y
    Int J Urol; 2004 Oct; 11(10):862-9. PubMed ID: 15479291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy).
    Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M
    Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
    Porter CR; Kodama K; Gibbons RP; Correa R; Chun FK; Perrotte P; Karakiewicz PI
    J Urol; 2006 Aug; 176(2):569-74. PubMed ID: 16813891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.
    Roehl KA; Han M; Ramos CG; Antenor JA; Catalona WJ
    J Urol; 2004 Sep; 172(3):910-4. PubMed ID: 15310996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
    Carver BS; Bianco FJ; Scardino PT; Eastham JA
    J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients.
    Kawakami S; Fukui I; Yonese J; Okubo Y; Yamamoto S; Tsukamoto T; Ishikawa Y
    Jpn J Clin Oncol; 2007 Jul; 37(7):528-33. PubMed ID: 17720739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy.
    Sengupta S; Myers RP; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
    J Urol; 2005 Dec; 174(6):2191-6. PubMed ID: 16280762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.
    Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
    Eur Urol; 2007 Jan; 51(1):121-8; discussion 128-9. PubMed ID: 16797831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of biochemical failure on long-term clinical outcome after radical prostatectomy for prostate cancer in Japan.
    Egawa S; Matsui Y; Matsumoto K; Suyama K; Arai Y; Kuwao S; Baba S
    Prostate Cancer Prostatic Dis; 2004; 7(2):152-7. PubMed ID: 15175664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
    Siddiqui SA; Sengupta S; Slezak JM; Bergstralh EJ; Zincke H; Blute ML
    J Urol; 2006 Sep; 176(3):1118-21. PubMed ID: 16890705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
    Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.
    Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD
    Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.
    Roehl KA; Eggener SE; Loeb S; Smith ND; Antenor JA; Catalona WJ
    Urol Oncol; 2006; 24(6):465-71. PubMed ID: 17138126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.